Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.

Hiroko Kotajima-Murakami,Ayumi Takano, Shinya Hirakawa,Yasukazu Ogai,Daisuke Funada,Yuko Tanibuchi, Eriko Ban,Minako Kikuchi,Hisateru Tachimori,Kazushi Maruo,Takahiro Kawashima,Yui Tomo,Tsuyoshi Sasaki,Hideki Oi,Toshihiko Matsumoto,Kazutaka Ikeda

Neuropsychopharmacology reports（2022）

引用 3|浏览5

暂无评分

摘要

The study was registered at the University Hospital Medical Information Network Clinical Trial Registry (no. UMIN000030849) and Japan Registry of Clinical Trials (no. jRCTs031180080). The main registration site is jRCT (https://jrct.niph.go.jp/).

查看译文

关键词

G protein-activated inwardly rectifying potassium channel,days of methamphetamine use,ifenprodil,methamphetamine use disorder,randomized-controlled trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要